U.S. signs $2 billion vaccine deal with Pfizer and BioNTech

Japan Today

22 Jul 2020 0 shares 1 views

U.S. signs $2 billion vaccine deal with Pfizer and BioNTech

Japan Today

Published 22 Jul 2020

The United States on on Tuesday signed a $1.95 billion agreement with U.S. pharma giant Pfizer and Germany's BioNTech for 100 million doses of their experimental COVID-19 vaccine,…

Full Article

Canadian government has yet to place orders for leading potential COVID vaccines

National Post 29 Jul 2020

OTTAWA — Major economies around the world have made large pre-orders for COVID-19 vaccines, but Canada hasn’t made the same..

"We have a winner": Trump administration inks $1.95-billion coronavirus vaccine deal, forcing taxpayers to enrich evil pharma giants
NaturalNews.com 24 Jul 2020
FTSE 100 clinging on to gains as sterling rallies
Proactive Investors 23 Jul 2020
FTSE 100 shrugs off latest episode in US-China muscle-flexing contest
Proactive Investors 23 Jul 2020
Sensex, Nifty Seen Flat To Higher
RTTNews 23 Jul 2020

More coverage

U.S. Agrees To Buy 100 Million Doses Of COVID-19 Vaccine

Newsy 22 Jul 2020

Watch VideoThe Trump administration has reached a deal with Pfizer and BioNTech to secure up to 600 million doses of a COVID-19..

US cuts $1.95 billion deal with Pfizer for 100 million doses of COVID-19 vaccine
USATODAY.com 22 Jul 2020
US spends $2 billion to secure COVID-19 vaccine
Ars Technica 22 Jul 2020
Coronavirus: US signs $2bn deal with Pfizer and BioNTech to produce 100 million vaccine doses by December
Independent 22 Jul 2020
Pfizer and BioNTech Ink Deal with U.S. Government for Big Coronavirus Vaccine Purchase
Motley Fool 22 Jul 2020

U.S. signs $2 billion vaccine deal with Pfizer and BioNTech

U.S. signs $2 billion vaccine deal with Pfizer and BioNTech

You might like

Related news coverage

Canadian government has yet to place orders for leading potential COVID vaccines

Advertisement

More coverage

U.S. Agrees To Buy 100 Million Doses Of COVID-19 Vaccine